| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | thymidylate kinase activity | 4.60e-05 | 2 | 136 | 2 | GO:0004798 | |
| GeneOntologyMolecularFunction | alpha-aminoacyl-tRNA binding | 1.38e-04 | 3 | 136 | 2 | GO:1904678 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.34e-04 | 18 | 136 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine transfer activity | 2.74e-04 | 4 | 136 | 2 | GO:1904121 | |
| GeneOntologyMolecularFunction | glycolipid transfer activity | 2.74e-04 | 4 | 136 | 2 | GO:0017089 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 3.24e-04 | 20 | 136 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 5.63e-04 | 24 | 136 | 3 | GO:0120020 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 6.15e-04 | 57 | 136 | 4 | GO:0120013 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 6.37e-04 | 25 | 136 | 3 | GO:0120015 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transfer activity | 6.78e-04 | 6 | 136 | 2 | GO:0120019 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.94e-04 | 28 | 136 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | dTDP biosynthetic process | 4.25e-05 | 2 | 135 | 2 | GO:0006233 | |
| GeneOntologyBiologicalProcess | dTDP metabolic process | 4.25e-05 | 2 | 135 | 2 | GO:0046072 | |
| GeneOntologyBiologicalProcess | cilium movement | 5.66e-05 | 261 | 135 | 9 | GO:0003341 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 7.41e-05 | 210 | 135 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 8.73e-05 | 215 | 135 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 8.73e-05 | 215 | 135 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CFAP47 DNHD1 DYNC2H1 CAMSAP3 DNAH2 APOB TTLL8 FSIP2 BORCS5 CLN3 AP3D1 PLTP | 9.85e-05 | 493 | 135 | 12 | GO:0007018 |
| GeneOntologyBiologicalProcess | dUDP biosynthetic process | 1.27e-04 | 3 | 135 | 2 | GO:0006227 | |
| GeneOntologyBiologicalProcess | dUDP metabolic process | 1.27e-04 | 3 | 135 | 2 | GO:0046077 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside diphosphate metabolic process | 1.27e-04 | 3 | 135 | 2 | GO:0009196 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside diphosphate biosynthetic process | 1.27e-04 | 3 | 135 | 2 | GO:0009197 | |
| GeneOntologyBiologicalProcess | ceramide transport | 2.08e-04 | 18 | 135 | 3 | GO:0035627 | |
| GeneOntologyBiologicalProcess | dTTP biosynthetic process | 2.53e-04 | 4 | 135 | 2 | GO:0006235 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside triphosphate biosynthetic process | 2.53e-04 | 4 | 135 | 2 | GO:0009212 | |
| GeneOntologyCellularComponent | motile cilium | CFAP47 DNHD1 DYNC2H1 PCDH11Y CAMSAP3 DNAH2 TTLL8 CEP164 FSIP2 MROH2B | 1.20e-04 | 355 | 137 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.78e-04 | 238 | 137 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | lateral element | 2.47e-04 | 19 | 137 | 3 | GO:0000800 | |
| GeneOntologyCellularComponent | PR-DUB complex | 2.54e-04 | 4 | 137 | 2 | GO:0035517 | |
| Domain | Vitellinogen_superhlx | 3.45e-07 | 3 | 132 | 3 | IPR011030 | |
| Domain | ARM-like | CAND1 CUL9 HUWE1 PACRGL NF1 MROH1 AP2B1 MROH2B AP4B1 STAG3 AP3D1 ARMC8 | 4.89e-07 | 270 | 132 | 12 | IPR011989 |
| Domain | - | CAND1 CUL9 PACRGL NF1 MROH1 AP2B1 MROH2B AP4B1 STAG3 AP3D1 ARMC8 | 5.13e-07 | 222 | 132 | 11 | 1.25.10.10 |
| Domain | ARM-type_fold | CAND1 CUL9 APOB HUWE1 PACRGL NF1 MROH1 AP2B1 MROH2B AP4B1 STAG3 AP3D1 ARMC8 | 8.54e-07 | 339 | 132 | 13 | IPR016024 |
| Domain | EamA | 2.26e-06 | 14 | 132 | 4 | PF00892 | |
| Domain | EamA_dom | 2.26e-06 | 14 | 132 | 4 | IPR000620 | |
| Domain | Thymidylate_kinase | 4.96e-05 | 2 | 132 | 2 | IPR018094 | |
| Domain | Vitellinogen_b-sht_N | 4.96e-05 | 2 | 132 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 4.96e-05 | 2 | 132 | 2 | IPR015819 | |
| Domain | - | 4.96e-05 | 2 | 132 | 2 | 2.30.230.10 | |
| Domain | VITELLOGENIN | 4.96e-05 | 2 | 132 | 2 | PS51211 | |
| Domain | THYMIDYLATE_KINASE | 4.96e-05 | 2 | 132 | 2 | PS01331 | |
| Domain | LPD_N | 4.96e-05 | 2 | 132 | 2 | SM00638 | |
| Domain | Lipid_transpt_N | 4.96e-05 | 2 | 132 | 2 | IPR001747 | |
| Domain | - | 4.96e-05 | 2 | 132 | 2 | 1.25.10.20 | |
| Domain | Vitellogenin_N | 4.96e-05 | 2 | 132 | 2 | PF01347 | |
| Domain | LBP_BPI_CETP | 9.37e-05 | 13 | 132 | 3 | PF01273 | |
| Domain | BPI/LBP/Plunc | 9.37e-05 | 13 | 132 | 3 | IPR032942 | |
| Domain | Bactericidal_perm-incr_a/b_dom | 9.37e-05 | 13 | 132 | 3 | IPR017943 | |
| Domain | Lipid-bd_serum_glycop_N | 9.37e-05 | 13 | 132 | 3 | IPR017942 | |
| Domain | Dynein_HC_stalk | 1.19e-04 | 14 | 132 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.19e-04 | 14 | 132 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.19e-04 | 14 | 132 | 3 | PF08393 | |
| Domain | MT | 1.19e-04 | 14 | 132 | 3 | PF12777 | |
| Domain | HEAT_REPEAT | 1.37e-04 | 70 | 132 | 5 | PS50077 | |
| Domain | DHC_fam | 1.48e-04 | 15 | 132 | 3 | IPR026983 | |
| Domain | Clathrin/coatomer_adapt-like_N | 1.48e-04 | 15 | 132 | 3 | IPR002553 | |
| Domain | Dynein_heavy | 1.48e-04 | 15 | 132 | 3 | PF03028 | |
| Domain | Adaptin_N | 1.48e-04 | 15 | 132 | 3 | PF01602 | |
| Domain | Dynein_heavy_dom | 1.48e-04 | 15 | 132 | 3 | IPR004273 | |
| Domain | HARE-HTH | 1.48e-04 | 3 | 132 | 2 | PF05066 | |
| Domain | ASXH | 1.48e-04 | 3 | 132 | 2 | PF13919 | |
| Domain | PHD_3 | 1.48e-04 | 3 | 132 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 1.48e-04 | 3 | 132 | 2 | IPR026905 | |
| Domain | ASXH | 1.48e-04 | 3 | 132 | 2 | IPR028020 | |
| Domain | AP_complex_bsu_1_2_4 | 1.48e-04 | 3 | 132 | 2 | IPR016342 | |
| Domain | ASX/ASX-like | 1.48e-04 | 3 | 132 | 2 | IPR024811 | |
| Domain | HB1/Asxl_HTH | 1.48e-04 | 3 | 132 | 2 | IPR007759 | |
| Domain | B2-adapt-app_C | 1.48e-04 | 3 | 132 | 2 | PF09066 | |
| Domain | B2-adapt-app_C | 2.95e-04 | 4 | 132 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 2.95e-04 | 4 | 132 | 2 | IPR015151 | |
| Domain | AP_beta | 4.89e-04 | 5 | 132 | 2 | IPR026739 | |
| Domain | Beta2_adaptin/TBP_C_dom | 7.30e-04 | 6 | 132 | 2 | IPR012295 | |
| Domain | - | 7.30e-04 | 6 | 132 | 2 | 3.30.310.10 | |
| Domain | - | DNHD1 NWD1 DYNC2H1 DTYMK NDST2 DNAH2 CMPK2 GTPBP1 ABCA7 MFN1 DHX9 GTPBP2 NLRC5 TAP1 | 8.18e-04 | 746 | 132 | 14 | 3.40.50.300 |
| Domain | DHC_N1 | 1.35e-03 | 8 | 132 | 2 | PF08385 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.35e-03 | 8 | 132 | 2 | IPR004160 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.35e-03 | 8 | 132 | 2 | IPR009028 | |
| Domain | Dynein_heavy_dom-1 | 1.35e-03 | 8 | 132 | 2 | IPR013594 | |
| Domain | GTP_EFTU_D3 | 1.35e-03 | 8 | 132 | 2 | PF03143 | |
| Domain | BPI1 | 1.73e-03 | 9 | 132 | 2 | SM00328 | |
| Domain | BPI2 | 1.73e-03 | 9 | 132 | 2 | SM00329 | |
| Domain | LBP_BPI_CETP | 1.73e-03 | 9 | 132 | 2 | PS00400 | |
| Domain | LBP_BPI_CETP_C | 2.15e-03 | 10 | 132 | 2 | PF02886 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 2.15e-03 | 10 | 132 | 2 | IPR009001 | |
| Domain | Laminin_G_1 | 2.62e-03 | 11 | 132 | 2 | PF00054 | |
| Domain | P-loop_NTPase | DNHD1 NWD1 DYNC2H1 DTYMK NDST2 DNAH2 CMPK2 GTPBP1 ABCA7 MFN1 DHX9 GTPBP2 NLRC5 TAP1 | 2.71e-03 | 848 | 132 | 14 | IPR027417 |
| Domain | Lipid-bd_serum_glycop_C | 3.12e-03 | 12 | 132 | 2 | IPR001124 | |
| Domain | RasGAP | 4.27e-03 | 14 | 132 | 2 | SM00323 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.27e-03 | 14 | 132 | 2 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 4.27e-03 | 14 | 132 | 2 | IPR011704 | |
| Domain | AAA_8 | 4.27e-03 | 14 | 132 | 2 | PF12780 | |
| Domain | RasGAP_CS | 4.27e-03 | 14 | 132 | 2 | IPR023152 | |
| Domain | AAA_5 | 4.27e-03 | 14 | 132 | 2 | PF07728 | |
| Domain | RasGAP | 4.90e-03 | 15 | 132 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.90e-03 | 15 | 132 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.90e-03 | 15 | 132 | 2 | PS50018 | |
| Domain | EFTu-like_2 | 7.04e-03 | 18 | 132 | 2 | IPR004161 | |
| Domain | RasGAP_dom | 7.04e-03 | 18 | 132 | 2 | IPR001936 | |
| Domain | GTP_EFTU_D2 | 7.04e-03 | 18 | 132 | 2 | PF03144 | |
| Domain | G_TR_2 | 7.04e-03 | 18 | 132 | 2 | PS51722 | |
| Pubmed | 2.30e-10 | 4 | 137 | 4 | 9056918 | ||
| Pubmed | Emergence of primate genes by retrotransposon-mediated sequence transduction. | 2.30e-10 | 4 | 137 | 4 | 17101974 | |
| Pubmed | 3.72e-06 | 59 | 137 | 5 | 20855565 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 CUL9 HUWE1 ABCA7 MST1R HAUS4 MROH1 MEGF6 FANCI CLN3 ZNF408 PPP1R15B CSPG4 NLRC5 ARRDC2 AP3D1 | 7.84e-06 | 1105 | 137 | 16 | 35748872 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.19e-05 | 268 | 137 | 8 | 33024031 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 16237061 | ||
| Pubmed | Human placenta secretes apolipoprotein B-100-containing lipoproteins. | 1.54e-05 | 2 | 137 | 2 | 15504742 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30226831 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 15795421 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 11054535 | ||
| Pubmed | A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion. | 1.54e-05 | 2 | 137 | 2 | 10713055 | |
| Pubmed | Molecular characterization of the murine thymidylate kinase gene. | 1.54e-05 | 2 | 137 | 2 | 8845311 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 38118446 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24842304 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 11358959 | ||
| Pubmed | Identification of Novel Phospholipid Transfer Protein Inhibitors by High-Throughput Screening. | 1.54e-05 | 2 | 137 | 2 | 31017809 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 14993689 | ||
| Pubmed | Functions of unconventional mammalian translational GTPases GTPBP1 and GTPBP2. | 1.54e-05 | 2 | 137 | 2 | 30108131 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 27487388 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19056372 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 28702990 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 9915855 | ||
| Pubmed | Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemia. | 1.54e-05 | 2 | 137 | 2 | 18027103 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 14732481 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 17690102 | ||
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 1.66e-05 | 13 | 137 | 3 | 22878500 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.67e-05 | 281 | 137 | 8 | 28706196 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GPI RNF130 DYNC2H1 DTYMK SMCHD1 APOB HUWE1 CEMIP2 STAT6 NUP205 NF1 MROH1 FANCI ENTPD6 ITM2B | 2.03e-05 | 1061 | 137 | 15 | 33845483 |
| Pubmed | 2.63e-05 | 15 | 137 | 3 | 21787333 | ||
| Pubmed | 3.60e-05 | 47 | 137 | 4 | 8812413 | ||
| Pubmed | 4.25e-05 | 97 | 137 | 5 | 22360420 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 11727199 | ||
| Pubmed | Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria. | 4.61e-05 | 3 | 137 | 2 | 31648943 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 19026012 | ||
| Pubmed | GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis. | 4.61e-05 | 3 | 137 | 2 | 33186095 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 17429319 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 18502767 | ||
| Pubmed | Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases. | 4.61e-05 | 3 | 137 | 2 | 25267367 | |
| Pubmed | Transcriptional activation by STAT6 requires the direct interaction with NCoA-1. | 4.61e-05 | 3 | 137 | 2 | 11574547 | |
| Pubmed | Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. | 4.61e-05 | 3 | 137 | 2 | 21562077 | |
| Pubmed | Mechanism of RAD51-dependent DNA interstrand cross-link repair. | 4.61e-05 | 3 | 137 | 2 | 21719678 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 17647275 | ||
| Pubmed | Mouse and human GTPBP2, newly identified members of the GP-1 family of GTPase. | 4.61e-05 | 3 | 137 | 2 | 10833435 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26224785 | ||
| Pubmed | Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. | 4.61e-05 | 3 | 137 | 2 | 19433756 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 16412590 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 10553000 | ||
| Pubmed | Identification of genes differentially induced by hypoxia in pancreatic cancer cells. | 4.61e-05 | 3 | 137 | 2 | 11688991 | |
| Pubmed | An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1. | 4.61e-05 | 3 | 137 | 2 | 12138096 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 24586211 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 25835095 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 38211723 | ||
| Pubmed | Complex genetic architecture in severe hypobetalipoproteinemia. | 4.61e-05 | 3 | 137 | 2 | 29540175 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 14757047 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 28684355 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 19020660 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 33751773 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22728071 | ||
| Pubmed | Vascular function during prolonged progression and regression of atherosclerosis in mice. | 4.61e-05 | 3 | 137 | 2 | 23307875 | |
| Pubmed | Microsomal triglyceride transfer protein expression during mouse development. | 4.61e-05 | 3 | 137 | 2 | 10744773 | |
| Pubmed | Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. | 4.61e-05 | 3 | 137 | 2 | 12628954 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPI DNHD1 CAND1 EMC1 DYNC2H1 SMCHD1 APOB HUWE1 MDH2 GTPBP1 LAP3 DHX9 NUP205 NF1 FANCI ITM2B ARMC8 | 4.76e-05 | 1425 | 137 | 17 | 30948266 |
| Pubmed | GPI CAND1 SEC24A APOB HUWE1 C2CD4C CEMIP2 DHX9 STIM1 GTPBP2 PPP1R15B AP3D1 | 6.19e-05 | 777 | 137 | 12 | 35844135 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 6.49e-05 | 20 | 137 | 3 | 29785026 | |
| Pubmed | Conservation of autosomal gene synteny groups in mouse and man. | 6.49e-05 | 20 | 137 | 3 | 662012 | |
| Pubmed | Derlin-1 promotes ubiquitylation and degradation of the epithelial Na+ channel, ENaC. | 6.72e-05 | 55 | 137 | 4 | 28137758 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 30782561 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 24903096 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 7741021 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 18645210 | ||
| Pubmed | Novel missense MTTP gene mutations causing abetalipoproteinemia. | 9.19e-05 | 4 | 137 | 2 | 25108285 | |
| Pubmed | AP-1 and AP-3 facilitate lysosomal targeting of Batten disease protein CLN3 via its dileucine motif. | 9.19e-05 | 4 | 137 | 2 | 15598649 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 5496232 | ||
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 9.19e-05 | 4 | 137 | 2 | 34536441 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 26340669 | ||
| Pubmed | Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. | 9.19e-05 | 4 | 137 | 2 | 18369455 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 25474352 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 21339485 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 18267973 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 28062492 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 18519977 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 25201910 | ||
| Pubmed | Genetic factors controlling structure and expression of apolipoproteins B and E in mice. | 9.19e-05 | 4 | 137 | 2 | 3034900 | |
| Pubmed | NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma. | 9.19e-05 | 4 | 137 | 2 | 23318450 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 19737859 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RNF130 CAND1 DTYMK SMCHD1 HUWE1 GTPBP1 DHX9 NF1 FANCI RAVER1 | 1.09e-04 | 582 | 137 | 10 | 20467437 |
| Pubmed | 1.14e-04 | 24 | 137 | 3 | 25009997 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SEC24A CARMIL1 CAMSAP3 GTPBP1 CEP164 NUP205 HAUS4 BORCS5 BRCA2 WDCP AP4B1 RAVER1 | 1.48e-04 | 853 | 137 | 12 | 28718761 |
| Pubmed | HIV-1 matrix protein: a mysterious regulator of the viral life cycle. | 1.53e-04 | 5 | 137 | 2 | 17210199 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 17142808 | ||
| Pubmed | Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. | 1.53e-04 | 5 | 137 | 2 | 15199141 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 25765938 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 12072427 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 37315736 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 12072432 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 CAMSAP3 DNAH2 ARHGAP9 EVPL HUWE1 DHX9 NUP205 MEGF6 TRPM3 ZNF408 | 1.68e-04 | 736 | 137 | 11 | 29676528 |
| Pubmed | Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. | 1.70e-04 | 293 | 137 | 7 | 31741433 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 1.82e-04 | 28 | 137 | 3 | 27002738 | |
| Pubmed | 2.03e-04 | 29 | 137 | 3 | 20972250 | ||
| Pubmed | 2.08e-04 | 513 | 137 | 9 | 25798074 | ||
| GeneFamily | BPI fold containing | 4.48e-05 | 16 | 80 | 3 | 456 | |
| GeneFamily | Solute carriers | SLC39A4 SLC35G6 SLC35G4 SLC41A3 SLC35G3 SLC35G5 SLC16A7 SLC4A9 | 3.55e-04 | 395 | 80 | 8 | 752 |
| GeneFamily | Maestro heat like repeat containing | 1.04e-03 | 11 | 80 | 2 | 636 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.52e-03 | 17 | 80 | 2 | 1197 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | CYP3A4 SEC24A SHBG SLC39A4 APOB BHLHE40 FAAH AGXT2 RASSF6 WDCP QPRT MTTP IGSF1 | 4.93e-06 | 535 | 137 | 13 | MM3635 |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CAND1 SEC24A SMCHD1 NDST2 HUWE1 CEMIP2 NF1 GVINP1 BRCA2 AP2B1 MMUT ARMC8 | 7.85e-06 | 475 | 137 | 12 | M40979 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.03e-07 | 200 | 137 | 8 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.03e-07 | 200 | 137 | 8 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.47e-06 | 195 | 137 | 7 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1-Excitatory_Neuron.Slc17a7.Parm1.Fos_(Deep_layer_pyramidal_cells--layer_5_(IEG))|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.03e-06 | 77 | 137 | 5 | 4879a1a72b950dadb78bc0312be75f1a32b935d5 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.79e-06 | 140 | 137 | 6 | 8abbd5dc799943b49cd0045d0da405c3f3d0db6b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.79e-06 | 140 | 137 | 6 | e4689232c473d239b07a7fbcaaa3414fbd9badea | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Lung / Manually curated celltypes from each tissue | 1.31e-05 | 167 | 137 | 6 | dcbcc658082910838c8082d71a64917055086cc4 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 170 | 137 | 6 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 137 | 6 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 137 | 6 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 137 | 6 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | control-Myeloid-Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.24e-05 | 196 | 137 | 6 | 9c8623232c47af5de9f360fd5c5113362e37c6c9 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 3.24e-05 | 196 | 137 | 6 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.33e-05 | 197 | 137 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.43e-05 | 198 | 137 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 3.43e-05 | 198 | 137 | 6 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.43e-05 | 198 | 137 | 6 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.43e-05 | 198 | 137 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-05 | 198 | 137 | 6 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.53e-05 | 199 | 137 | 6 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 137 | 6 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 199 | 137 | 6 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 3.53e-05 | 199 | 137 | 6 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 3.53e-05 | 199 | 137 | 6 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-05 | 199 | 137 | 6 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 137 | 6 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | TCGA-Lung|World / Sample_Type by Project: Shred V9 | 1.01e-04 | 150 | 137 | 5 | 8c133206786e8f22bb70f2a7de9c0cb7f9ea9313 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 154 | 137 | 5 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 154 | 137 | 5 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 154 | 137 | 5 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 1.33e-04 | 159 | 137 | 5 | 595643e9433265308e5aab7f906229025701cf6a | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.41e-04 | 161 | 137 | 5 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 162 | 137 | 5 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 162 | 137 | 5 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 1.58e-04 | 165 | 137 | 5 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.64e-04 | 89 | 137 | 4 | eda156a61e7d14087cfdae5e733d6862834fb0e5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 168 | 137 | 5 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.72e-04 | 168 | 137 | 5 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 168 | 137 | 5 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.76e-04 | 169 | 137 | 5 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 1.81e-04 | 170 | 137 | 5 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-04 | 172 | 137 | 5 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 1.97e-04 | 173 | 137 | 5 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 175 | 137 | 5 | 1c7725f917f3d6b9e0a31ede9524690f408a5ea1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 175 | 137 | 5 | 86dfce849b2ec023a72f7e887fa681b117155e51 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-04 | 176 | 137 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.19e-04 | 177 | 137 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 178 | 137 | 5 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.25e-04 | 178 | 137 | 5 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 180 | 137 | 5 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 180 | 137 | 5 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 180 | 137 | 5 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-04 | 183 | 137 | 5 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 183 | 137 | 5 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.62e-04 | 184 | 137 | 5 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_progenitors|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 184 | 137 | 5 | fcb5dd4fb3fa79f3b6029fad32a474cacde35a3b | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 184 | 137 | 5 | 238eba615b4e04967d44ac7858a6673bdd7f67e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-04 | 184 | 137 | 5 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-04 | 184 | 137 | 5 | 603faafb7b289a3c0242c84fc800c050c8a092ea | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.62e-04 | 184 | 137 | 5 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-04 | 184 | 137 | 5 | c350504bfe0ec31cd2fc2199de9b5fff151a8c5e | |
| ToppCell | Club|World / Class top | 2.68e-04 | 185 | 137 | 5 | c3caf789e622ed515d143dc594158d52fdcffaef | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 186 | 137 | 5 | 3c4994a1a7db06a61da8170e45e06aaef7896592 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-04 | 186 | 137 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 186 | 137 | 5 | a583d6fc0f1e729f6e9fd18d7b49d6eab9ca32b9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-04 | 186 | 137 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.82e-04 | 187 | 137 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Club-club-14|World / Class top | 2.82e-04 | 187 | 137 | 5 | 4584de577d3736c89187e522497498e58d381c46 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 2.82e-04 | 187 | 137 | 5 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 2.89e-04 | 188 | 137 | 5 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.89e-04 | 188 | 137 | 5 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 2.89e-04 | 188 | 137 | 5 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 2.89e-04 | 188 | 137 | 5 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 189 | 137 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 3.03e-04 | 190 | 137 | 5 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-04 | 190 | 137 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.11e-04 | 191 | 137 | 5 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.11e-04 | 191 | 137 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 3.11e-04 | 191 | 137 | 5 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.11e-04 | 191 | 137 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-04 | 191 | 137 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.11e-04 | 191 | 137 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.11e-04 | 191 | 137 | 5 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-04 | 192 | 137 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-04 | 192 | 137 | 5 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-04 | 192 | 137 | 5 | 859a32c9e4ed6961897b2ccaecde73a599471df9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-04 | 192 | 137 | 5 | 89e1da82fa2069dac7adb9cba3e8b6c0179e0dc5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-04 | 192 | 137 | 5 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 193 | 137 | 5 | 40eedc1490c113403bc7c12a6bdf976f4f8bca84 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.26e-04 | 193 | 137 | 5 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.26e-04 | 193 | 137 | 5 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.26e-04 | 193 | 137 | 5 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.26e-04 | 193 | 137 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | (06)_Krt4/13+-(0)_uninjured|(06)_Krt4/13+ / shred by cell type and Timepoint | 3.27e-04 | 9 | 137 | 2 | baf55476ddf9a2d1e6741a73bcc92ac9d00c2bca | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 194 | 137 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.34e-04 | 194 | 137 | 5 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 3.34e-04 | 194 | 137 | 5 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 194 | 137 | 5 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.34e-04 | 194 | 137 | 5 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.34e-04 | 194 | 137 | 5 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| Disease | immature platelet count | 1.30e-04 | 106 | 135 | 5 | EFO_0803544 | |
| Disease | immature platelet measurement | 2.24e-04 | 119 | 135 | 5 | EFO_0803541 | |
| Disease | total lipids in very large HDL measurement | 2.42e-04 | 66 | 135 | 4 | EFO_0022312 | |
| Disease | cholesterol in very large HDL measurement | 2.88e-04 | 69 | 135 | 4 | EFO_0022229 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 5.99e-04 | 36 | 135 | 3 | EFO_0022257 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 7.59e-04 | 39 | 135 | 3 | EFO_0022332 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 9.13e-04 | 10 | 135 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Fanconi anemia (is_implicated_in) | 9.13e-04 | 10 | 135 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | systemic lupus erythematosus | CARMIL1 PPCDC ARHGAP9 SIRPB1 PXK SYNGAP1 STIM1 AGXT2 PLCL1 TAP1 CCDC136 | 1.15e-03 | 799 | 135 | 11 | MONDO_0007915 |
| Disease | estradiol measurement | 1.66e-03 | 110 | 135 | 4 | EFO_0004697 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.72e-03 | 111 | 135 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.74e-03 | 276 | 135 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Fanconi anemia | 1.82e-03 | 14 | 135 | 2 | cv:C0015625 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.82e-03 | 14 | 135 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | immature platelet fraction | 1.90e-03 | 114 | 135 | 4 | EFO_0009187 | |
| Disease | Polydactyly | 2.08e-03 | 117 | 135 | 4 | C0152427 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 2.10e-03 | 15 | 135 | 2 | EFO_0022328 | |
| Disease | Hypertriglyceridemia | 2.10e-03 | 15 | 135 | 2 | C0020557 | |
| Disease | amenorrhea, response to antineoplastic agent | 2.10e-03 | 15 | 135 | 2 | EFO_0010269, GO_0097327 | |
| Disease | Prostatic Neoplasms | 2.17e-03 | 616 | 135 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.17e-03 | 616 | 135 | 9 | C0376358 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.17e-03 | 56 | 135 | 3 | EFO_0022333 | |
| Disease | X-21410 measurement | 2.39e-03 | 16 | 135 | 2 | EFO_0800813 | |
| Disease | angina pectoris | 2.65e-03 | 125 | 135 | 4 | EFO_0003913 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.65e-03 | 60 | 135 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 2.65e-03 | 60 | 135 | 3 | EFO_0022237 | |
| Disease | Inborn Errors of Metabolism | 2.70e-03 | 17 | 135 | 2 | C0025521 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.70e-03 | 17 | 135 | 2 | EFO_0022232 | |
| Disease | free cholesterol in HDL measurement | 2.78e-03 | 61 | 135 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 2.78e-03 | 61 | 135 | 3 | EFO_0022293 | |
| Disease | free cholesterol in very large HDL measurement | 2.91e-03 | 62 | 135 | 3 | EFO_0022273 | |
| Disease | aspartate aminotransferase measurement | CARMIL1 DNAH2 ARHGAP9 PXK BORCS5 NF1 HMCN2 TRPM3 NLRC5 MMUT SAMD4A | 3.00e-03 | 904 | 135 | 11 | EFO_0004736 |
| Disease | Bone marrow hypocellularity | 3.03e-03 | 18 | 135 | 2 | C1855710 | |
| Disease | total lipids in HDL measurement | 3.04e-03 | 63 | 135 | 3 | EFO_0022307 | |
| Disease | platelet measurement | 3.36e-03 | 315 | 135 | 6 | EFO_0005036 | |
| Disease | Juvenile Myelomonocytic Leukemia | 3.38e-03 | 19 | 135 | 2 | C0349639 | |
| Disease | ovulation | 3.38e-03 | 19 | 135 | 2 | GO_0030728 | |
| Disease | response to methotrexate, neurotoxicity | 3.38e-03 | 19 | 135 | 2 | EFO_0011057, GO_0031427 | |
| Disease | phospholipids in very large HDL measurement | 3.47e-03 | 66 | 135 | 3 | EFO_0022298 | |
| Disease | viral load | 3.59e-03 | 136 | 135 | 4 | EFO_0010125 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.62e-03 | 67 | 135 | 3 | C3463824 | |
| Disease | Malignant neoplasm of breast | TRERF1 GPI ADAMTS1 CYP3A4 DYNC2H1 FAAH NF1 BRCA2 WDCP NLRC5 NCOA1 DOP1A | 3.90e-03 | 1074 | 135 | 12 | C0006142 |
| Disease | mitochondrial DNA measurement | 4.09e-03 | 328 | 135 | 6 | EFO_0006312 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.12e-03 | 21 | 135 | 2 | EFO_0022246 | |
| Disease | serum metabolite measurement | CYP3A4 SHBG APOB ABCA7 FAAH AGXT2 PACRGL MROH1 PTCD1 PLCL1 PLTP | 4.19e-03 | 945 | 135 | 11 | EFO_0005653 |
| Disease | triglycerides to total lipids in small HDL percentage | 4.44e-03 | 72 | 135 | 3 | EFO_0022336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLPEPLKVIFLVNSG | 156 | Q9BYV1 | |
| PKDPLLFIQLNELLG | 51 | Q96Q91 | |
| PEALGKLPLHQQLLL | 321 | P59826 | |
| LNVALDVGIPLPKVL | 436 | P59826 | |
| IGRLKLLLPDLQPQS | 446 | Q8IUX8 | |
| LLLSPKGEVARALLP | 526 | Q86VW2 | |
| LKKLAPPLVTLLSGE | 281 | P63010 | |
| LQVTIALEGPLAPLK | 1226 | Q6UVK1 | |
| LLQALKPIPPLNLET | 396 | O14503 | |
| AGFLPSLLKVLLLPL | 6 | Q8NEB7 | |
| SLLKVLLLPLAPAAA | 11 | Q8NEB7 | |
| LLSVPKEFLLLGPQQ | 206 | Q7Z2Y8 | |
| IKLNDTLLLGPDPLG | 421 | O00178 | |
| SLDLLKVFLNILPPL | 381 | Q9BX10 | |
| AAPFLLGLLTNELPL | 66 | Q5T440 | |
| APLKPDLALLAINTL | 76 | Q9Y6B7 | |
| NLILLNKPPEFLLLS | 286 | Q4W4Y0 | |
| LLLLLLPTSGQEKPT | 11 | Q86Y34 | |
| ILISLLDKPELGPVI | 356 | Q5JWR5 | |
| ILLKDSIQLSLPAPG | 1926 | Q5JWR5 | |
| LLLEKVHQLPPGLLS | 1736 | Q96M86 | |
| LLGEKELPLTSLLPF | 406 | Q8TF44 | |
| LPGPLALTSLEHKLL | 156 | Q9P1Y5 | |
| VDIPGTSKLLLELPL | 286 | Q8TBH0 | |
| LLQGSLPLEKVLPPA | 1111 | Q8IXJ9 | |
| TQLLQGNLPLEKVLP | 1751 | Q9C0F0 | |
| RLKPLILGKLLFAPD | 286 | Q8IZY2 | |
| IIKLFGALTPLEPRL | 241 | O14617 | |
| LITLPLVGKPLNLDR | 696 | Q149M9 | |
| GKGLLPEPNILQLLN | 321 | Q8IY67 | |
| DIPLLQRLLQGPSEK | 281 | Q6ZTQ3 | |
| GPVPTLLLLAAALLA | 31 | Q9UHI8 | |
| LNILKALGIVPNLPC | 306 | Q86XS8 | |
| PLLSLLAGSLQGKPL | 11 | Q9UK05 | |
| LQSLLTPQPPLLKAL | 1536 | Q92621 | |
| IIENLKPLLPAGIQD | 476 | Q8IWA4 | |
| KLNLPINIIGLAPLC | 321 | P28838 | |
| LLPPLKLEACILTQG | 641 | Q9NVI1 | |
| LILPIGSIKPLDFSL | 1111 | Q86XX4 | |
| PPRNLLELLINIKAG | 176 | Q9Y287 | |
| GALKRLILNLDPLPT | 51 | Q6ZRQ5 | |
| AKVIQPDGVLLLLPR | 371 | Q9Y2Z2 | |
| LKDGLPLPLSQRTLL | 3356 | Q8NDA2 | |
| IGQPLSLLLKNSPLV | 36 | P40926 | |
| AQLLDLPLGVKLPVI | 46 | Q5CZC0 | |
| GKLTLIDPETLLPRL | 956 | Q86VP6 | |
| TQIPLKLSLGGLLQP | 471 | P08684 | |
| EVTPLRLELQKLPGL | 101 | Q6H9L7 | |
| ALESLALIPLQAPLK | 401 | P55058 | |
| ALKNALLPEGIPSLL | 476 | P55157 | |
| RKDPLSGLLLLPAAL | 2001 | Q92817 | |
| VLLGPPLAGKLVDLT | 386 | O60669 | |
| PLEKNAPVLLALLGI | 311 | P06744 | |
| LALLLPPVTLAALVD | 6 | Q15274 | |
| LIAALQILLKDPAPE | 1611 | Q8NDA8 | |
| QKGLLPLVTILGLPN | 796 | Q7Z6Z7 | |
| LATILPGLPELRKID | 1626 | Q86WI3 | |
| LSQPILLELEAPLKI | 46 | P62140 | |
| LALDALPPELLVQVL | 16 | Q96EF6 | |
| PQLLEAVLKLLPLDT | 56 | A2VDF0 | |
| KTLGLKEVSPLPLNL | 3696 | Q8NCM8 | |
| DLTLLDSPIKVPLLL | 2016 | P04114 | |
| IIPALLQGLLSPDLK | 106 | Q8IUR7 | |
| LLKPDLILLLTVSPE | 366 | Q5EBM0 | |
| LELLVTGLLPKPSLL | 1056 | Q8N6C5 | |
| ILPPLLKDSVAAPLL | 206 | Q8NB78 | |
| GILENLPLLDILKPG | 66 | Q9NP55 | |
| PLILVGEPSIKRNLL | 2276 | P51587 | |
| LPDVFGLVVLPLELK | 326 | Q9Y3I1 | |
| LQEIPTFQPLLKGLL | 56 | Q969J3 | |
| PLDKLPGLNTATILL | 6 | Q9NSP4 | |
| GLQLLAKPELTPLGI | 701 | Q9UHN6 | |
| PILLLLQVKPLNGSP | 16 | Q96L11 | |
| IHLPQIPGKLLFSLV | 246 | Q8IWT3 | |
| LSPEPLKALLLGLAC | 436 | Q5VZK9 | |
| LLIGLPSGAILSLPK | 861 | Q8N766 | |
| GLLAFLVKPLLPRLS | 416 | O00519 | |
| IPPLLGLEKADLLEL | 136 | Q9H6D7 | |
| KLLALDPSPLNVVLL | 4176 | Q9P225 | |
| IALPPKGNIDISLLF | 2816 | Q6ZTR5 | |
| LAPPPLLKDLLRQEL | 71 | Q8N4L8 | |
| DELTPLGRILAKLPI | 846 | Q08211 | |
| GKLLLLLPALRSISP | 341 | Q9Y466 | |
| LIGNLLKDLNLSLIP | 71 | Q9BZA8 | |
| ELLLVKGAPEKAIPL | 141 | Q8N7B6 | |
| LALVLLLLPAVPVGA | 16 | O75095 | |
| LPIALLLKLRGDPLL | 81 | Q96KT7 | |
| LPIALLLKLRGDPLL | 81 | Q8N808 | |
| RVQLISGPPAKLLLI | 1246 | A6NHR9 | |
| PLLDKLVLPVLPGAL | 171 | P07988 | |
| LEPGRLKLQLASIVP | 66 | Q9H0A3 | |
| PLVLKATAGLRLLPG | 176 | O75354 | |
| PLGLLLHPFKDLVQL | 406 | O95486 | |
| QLLPTLEKAAQLPGL | 816 | Q15788 | |
| KFLLLGLIEDPELQP | 11 | Q8NG99 | |
| LSPLVLGQKLGALEP | 511 | Q9NQV8 | |
| LLALLESPKALTPGL | 126 | Q6P5W5 | |
| LDLPLVLGLPLQLKL | 296 | P04278 | |
| LKPLAAALGLALPGL | 96 | Q03518 | |
| DLLTLVPPLVGLKGN | 101 | Q96GZ6 | |
| IPPGVFSKLENLLLL | 186 | P51888 | |
| PLLRKQLEGGLALPS | 406 | P0DKV0 | |
| TRLPELLQPLEGKNI | 551 | Q7Z745 | |
| LLSQLLAPLPGLLQK | 66 | Q5SWA1 | |
| QLKALDTVLFGPPLL | 191 | Q13586 | |
| PLPKSGLLLKSQELL | 591 | Q96JN2 | |
| PKPKATLSLLQLGLD | 1436 | Q9UPV0 | |
| LPTLVIKLLAPLGLH | 106 | Q13286 | |
| LKLPLLVSKLLDIPG | 31 | Q96CD2 | |
| APTAPLLVALLLGPK | 366 | O00241 | |
| LPIALLLKLRGDPLL | 81 | P0C7Q5 | |
| KGLLEKAVLLLDFPP | 281 | Q4W5G0 | |
| GLPPIASLKQCLLTL | 916 | Q15111 | |
| LKEEKGLPLALLAPL | 656 | A6PVC2 | |
| GLRPDKPLEAQLLLN | 651 | Q9C0A1 | |
| LTEHLIPLLPQLLAK | 576 | Q9UJ98 | |
| EALLKLGPLPRLLND | 706 | Q96PV0 | |
| PGKLPIQLQALSLPL | 396 | P42226 | |
| SGLKVILGILLPPSI | 796 | Q9HCF6 | |
| ILGILLPPSILSLEF | 801 | Q9HCF6 | |
| EPLLIRQGLIPKLVS | 101 | Q5T4T6 | |
| ILALKSLPRGLALGP | 51 | Q9H9D4 | |
| LPPLGSQGLSKEILL | 511 | O94964 | |
| PQDTLKLLPLLTGLF | 306 | Q9BSE2 | |
| RPKDVPGTLLNIALL | 1846 | P21359 | |
| LELSKLLSRLGQPVP | 856 | P52849 | |
| NKPLPVDDILQSLLG | 1461 | Q92576 | |
| LQIAGLSLPLPPKKL | 66 | Q7Z7A4 | |
| TGALKLFLRELPQPL | 631 | Q9BRR9 | |
| VLEKLPDLVRGLPTL | 91 | Q147U7 | |
| LPIALLLKLRGDPLL | 81 | P0C7Q6 | |
| LVLKQNRLGILPSIP | 431 | Q8NEG5 | |
| LGFPLLKPAVISQLE | 11 | P17027 | |
| LLKTLLDIPANPTGL | 131 | Q5MNZ9 | |
| IPGILVPDLIAFNLK | 336 | Q9H6R7 | |
| ALLPVLAKRGLVPNL | 541 | O75127 | |
| FLLLLLLPAKPAAGE | 11 | Q04912 | |
| SLLLTHLPLLKPGNL | 81 | Q9UPU9 | |
| TLANPLGTLNPLKLL | 46 | Q96QR1 | |
| PLKLLLSSLGIPVNH | 56 | Q96QR1 | |
| LPLLLPVLGAGSLNK | 16 | Q96RL6 | |
| APGLLPLDQLSLIKP | 1141 | Q96PN7 | |
| DVGLPKPDLVLFLQL | 121 | P23919 | |
| LVPELIKELNSLGRP | 681 | P22033 |